|Articles|July 27, 2015
Janet Freeman-Daily on Why Patients Should Attend the ASCO Meeting
Author(s)Janet Freeman-Daily
Janet Freeman-Daily on why patients should attend the annual meeting of the American Society of Clinical Oncology (ASCO).
Advertisement
We spoke with Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago. Here, Freeman-Daily discusses why patients should attend the meeting.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Cancer and Answering the Phone
2
Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC
3
Grieving After Cancer: Advice for Those Grieving and Supporting Them
4
FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma
5